While not found in nature, abolishing the ability of IgG antibodies to interact with FcγR through genetic engineering the Fc portion of IgG (LALA mutation) also ablates many of the infection-enhancing properties of DENV-reactive IgG both in vitro (35) and in vivo (49, 50). This evidence concerns the gene FCGR2A and infection.